Front Matter
Total Page:16
File Type:pdf, Size:1020Kb
CANCER GENOMICS & PROTEOMICS Volume 7, Number 3, May-June 2010 ISSN (print): 1109-6535; ISSN (online): 1790-6245 Published by the International Institute of Anticancer Research Editorial Policy. CANCER GENOMICS & PROTEOMICS (CGP) welcomes the submission of high quality original articles and reviews on all aspects of the application of CANCER genomic and proteomic technologies to experimental and clinical cancer research. The Journal’ s scientific spectrum includes: (a) molecular causes of carcinogenesis, cancer GENOMICS & progression and metastasis; (b) structural and functional aspects of genes in the cancer cell; (c) advances in genomic and proteomic technologies applicable to cancer research; (d) anticancer drug design and drug development. PROTEOMICS CGP will also accept abstracts and proceedings of scientific Print ISSN: 1109-6535, Online ISSN: 1790-6245 meetings for publication, following consideration and approval by the Editorial Board. Editor-in-Chief: A main aim of CGP is to ensure the prompt and confidential Sunnybrook Research Institute, University of Toronto, ARUN SETH, review, and rapid publication of original works and reviews, Toronto, ON, Canada generally within 2-4 months from submission or 1-2 months Managing Editor: from acceptance. J.G. DELINASSIOS, International Institute of Anticancer Research For more information about CANCER GENOMICS & (IIAR), Kapandriti, Attiki, Greece PROTEOMICS, IIAR and the Conferences, please visit the IIAR website: www.iiar-anticancer.org Editorial Board Publication Data: CANCER GENOMICS & PROTEOMICS L. A. Aaltonen, Helsinki, Finland P. J. McCormick, Rensselaer, NY, USA (CGP) is published bimonthly. Each annual volume comprises R. Abagyan, La Jolla, CA, USA J. D. Minna, Dallas, TX, USA six issues. Annual Author and Subject Indexes are included in F. Ahmed, Greenville, NC, USA F. Mitelman, Lund, Sweden the sixth issue of each volume. CANCER GENOMICS & S. Antonarakis, Geneva, Switzerland P. Nelson, Seattle, WA, USA D.-T. Bau, Taiwan, ROC C. Nicot, Kansas City, KS, USA PROTEOMICS Vol. 1 (2004) and onwards appears online with A. M, Burger, Detroit, MI, USA L. O’Driscoll, Dublin, Ireland Stanford University HighWire Press. M. R. Chance, Cleveland, OH, USA I. Pastan, Bethesda, MD, USA Copyright: On publication of a manuscript in CGP, which is a A. M. Chinnaiyan, Ann Arbor, MI, USA C. D. Platsoucas, Philadelphia, PA, USA copyrighted publication, the legal ownership of all published B. F. C. Clark, Aarhus, Denmark J. Quackenbush, Boston, MA, USA parts of the paper passes from the Author(s) to the Journal. R. Clarke, Washington, DC, USA J. S. Rader, Milwaukee, WI, USA N. E. Davidson, Pittsburgh, PA, USA A. Raouf, Winnipeg, MB, Canada Manuscripts, correspondence, requests for sample copies and I. Dunham, Cambridge, UK G. Rasty, Toronto, ON, Canada orders should be addressed to: Dr. John G. Delinassios, Managing T. Efferth, Mainz, Germany G. Rechavi, Tel-Hashomer, Israel Editor, Editorial Office, Cancer Genomics & Proteomics, 1st km J. A. Fernandez-Pol, Chesterfield, MO, USA R. H. Reeves, Baltimore, MD, USA Kapandritiou-Kalamou Rd., P.O. Box 22, Kapandriti, Attiki C.V. Forst, Los Alamos, NM, USA K. L. Reichelt, Oslo, Norway 19014, Greece. Tel: +30 22950 52945, Fax: +30 22950 53389, e- M. Fountoulakis, Basel, Switzerland T. Ried, Bethesda, MD, USA mail: [email protected] D. S. Gerhard, Bethesda, MD, USA G. Rimbach, Kiel, Germany J. W. Gray, San Francisco, CA, USA K. D. Rodland, Richland, WA, USA Manuscripts from North America may be sent to the Editor- B. B. Haab, Grand Rapids, MI, USA Y. Sakaki, Yokohama, Japan in-Chief, Prof. A. Seth, CGP, Laboratory of Molecular C.-H. Heldin, Uppsala, Sweden C. Sansom, London, UK Pathology, Sunnybrook Research Institute, University of J. D. Hoheisel, Heidelberg, Germany N. A. Saunders, Queensland, Australia Toronto, 2075 Bayview Avenue, Room S112a, Toronto, R. P. Huang, Atlanta, GA, USA J. Schneider, Madrid, Spain ON, Canada M4N 3M5. Fax: 416 480 5737. E-mail: T. H. M. Huang, Columbus, OH, USA O. J. Semmes, Norfolk, VA, USA [email protected] S. C. Jhanwar, New York, NY, USA G. V. Sherbet, Newcastle-upon-Tyne, UK Annual Subscription (print & online) Rates 2010: Institutional V. C. Jordan, Chicago, IL, USA K. K. Singh, Buffalo, NY, USA J. Ju, Stony Brook, NY, USA S. Smith, Duarte, CA, USA subscription, Euro 800.00 - online, print or print & online; A. Kallioniemi, Tampere, Finland J. C. Stretford, Southampton, UK Personal subscription, Euro 400.00 - online, print or print & O. P. Kallioniemi, Turku, Finland J. M. Trent, Phoenix, AZ, USA online; Prices include rapid delivery and insurance. K. Khalili, Philadelphia, PA, USA G. Tsangaris, Athens, Greece Subscription Orders: Orders can be placed at agencies, , D. G. Kieback Dresden, Germany L.-C. Tsui, Toronto, ON, Canada bookstores, or directly with the Publisher. Cheques should be S. D. Kottaridis, Athens, Greece G. F. Vande Woude, Grand Rapids, MI, USA made payable to J.G. Delinassios, Managing Editor, Athens, B. Léyland-Jones, Montreal, QC, Canada D. K. Watson, Charleston, SC, USA Greece, and should be sent to the Editorial Office. P. Lichter, Heidelberg, Germany K. Williams, New Haven, CT, USA A. Lindblom, Stockholm, Sweden A. T. Yeung, Philadelphia, PA, USA Advertising: All correspondence and rate requests should be G. Lubec, Vienna, Austria H. Zhang, New Haven, CT, USA addressed to the Editorial Office. J. Lyons-Weiler, Pittsburgh, PA, USA Book Reviews: Recently published books and journals should Editorial Office: International Institute of Anticancer Research be sent to the Editorial Office. Reviews will be published within 2-4 months. 1st km Kapandritiou-Kalamou Rd., P.O. Box 22, Kapandriti, Attiki 19014, Greece. The Editors and Publishers of CANCER GENOMICS & Tel: +30 22950 52945, Fax: +30 22950 53389 PROTEOMICS accept no responsibility for the opinions E-mails: expressed by the contributors or for the content of [email protected] (Editorial Office) advertisements appearing therein. [email protected] (Managing Editor) www.iiar-anticancer.org Copyright© 2010, International Institute of Anticancer Research PRINTED ON ACID-FREE PAPER (Dr. John G. Delinassios), All rights reserved Front cover photograph: Figure 5, page 162, this issue. PHOTOCOMPOSITION BY IIAR PRINTED BY ENTYPO, ATHENS, GREECE CANCER GENOMICS & PROTEOMICS Print ISSN: 1109-6535 Online ISSN: 1790-6245 VOLUME 7, No 3 2010 CANCER GENOMICS & PROTEOMICS 7: (2010) Editorial Board A. Seth Editor-in-Chief Laboratory of Molecular Pathology, Sunnybrook Research Institute, Sunnybrook Health Sciences Centre and University of Toronto, Toronto, Ontario, Canada J.G. Delinassios Managing Editor and Executive Publisher, International Institute of Anticancer Research, Athens, Greece L.A. Aaltonen Department of Medical Genetics, University of Helsinki, Finland R. Abagyan The Scripps Research Institute, La Jolla, CA, USA F. Ahmed Department of Radiation Oncology, East Carolina University School of Medicine, Greenville, NC, USA S. Antonarakis Division of Medical Genetics, University of Geneva Medical School, Switzerland D.-T. Bau Terry Fox Cancer Research Lab, China Medical University Hospital, Taichung, Taiwan A.M. Burger Barbara Ann Karmanos Cancer Institute, Wayne State University, Detroit, MI, USA M.R. Chance Case Western Reserve University, Center for Proteomics and Bioinformatics, Cleveland, OH, USA A.M. Chinnaiyan Department of Pathology, University of Michigan Medical School, Ann Arbor, MI, USA B.F.C. Clark Department of Molecular Biology, University of Aarhus, Denmark R. Clarke Vincent T. Lombardi Cancer Center, Georgetown University School of Medicine, Washington, DC, USA N. E. Davidson University of Pittsburgh, Cancer Institute, Pittsburgh, PA, USA I. Dunham The Wellcome Trust Sanger Centre, Wellcome Trust Genome Campus, Cambridge, UK T. Efferth Department of Pharmaceutical Biology Institute of Pharmacy and Biochemistry, University of Maiz, Germany J.A. Fernandes-Pol Metalloproteomics, LLC, Chesterfield, MO, USA C.V. Forst McClintock Resource, Bioscience Division, Los Alamos National Laboratory, NM, USA M. Fountoulakis F. Hoffman-La Roche Pharmaceutical Research, Basel, Switzerland D.S. Gerhard NIH / NCI, Office of Cancer Genomics, Bethesda, MD, USA J.W. Gray Cancer Genetics Program, Comprehensive Cancer Center, University of California San Francisco, CA, USA B.B. Haab Van Andel Research Institute, Grand Rapids, MI, USA C.-H. Heldin Ludwig Institute for Cancer Research, Uppsala, Sweden J.D. Hoheisel Deutsches Krebsforschungszentrum, Genome Research and Bioinformatics, Heidelberg, Germany R.P. Huang Department of Gynecology and Obstetrics, Emory University School of Medicine, Atlanta, GA, USA T.H.M. Huang Comprehensive Cancer Center, Human Cancer Genetics Program, Ohio State University, Columbus, OH, USA S.C. Jhanwar Departments of Pathology and Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA V.C. Jordan Fox Chase Cancer Center, Philadelphia, PA, USA J. Ju Translational Research Laboratories, State University of New York, School of Medicine, Stony Brook, NY, USA A. Kallioniemi Laboratory of Cancer Genetics, Institute of Medical Technology, Tampere University Hospital, Finland O.P. Kallioniemi Medical Biotechnology Group, VTT Technical Research Centre of Finland, Turku, Finland K. Khalili College of Science and Technology, Center for Neurovirology and Cancer Biology, Temple University, Philadelphia, PA, USA D.G. Kieback DIAKO, Ev. Diakonie-Hospital, Bremen, Germany S.D. Kottaridis